We are live on ! Find out more
PMC

PharMerica Corporation
PMC

Delisted

PMC was delisted on the 7th of December, 2017.

157 hedge funds and large institutions have $756M invested in PharMerica Corporation in 2017 Q2 according to their latest regulatory filings, with 15 funds opening new positions, 57 increasing their positions, 50 reducing their positions, and 9 closing their positions.

New
Increased
Maintained
Reduced
Closed

205% more call options, than puts

Call options by funds: $656K | Put options by funds: $215K

67% more first-time investments, than exits

New positions opened: 15 | Existing positions closed: 9

14% more repeat investments, than reductions

Existing positions increased: 57 | Existing positions reduced: 50

11% more capital invested

Capital invested by funds: $679M → $756M (+$77.8M)

3% more funds holding

Funds holding: 152157 (+5)

0% more funds holding in top 10

Funds holding in top 10: 11 (0)

Holders
157
Holders Change
+5
Holders Change %
+3.29%
% of All Funds
3.91%
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.02%
New
15
Increased
57
Reduced
50
Closed
9
Calls
$656K
Puts
$215K
Net Calls
+$441K
Net Calls Change
-$99K

PMC Hedge Fund Activity: Q2 2017 in Review

157 of the 4,011 institutional investors tracked by Wall St. Rank reported a position in PharMerica Corporation (PMC) for Q2 2017, worth a combined $756M — up 11% from $679M a quarter earlier.

Buyers outnumbered sellers: 15 funds opened new PMC positions and 9 closed out — a net gain of 6 holders — while 57 added to existing stakes and 50 trimmed.

The largest buyer was Discovery Group I, adding an estimated $12.1M. The largest seller was Fidelity Investments, cutting an estimated $20.7M.

  • 157 institutional investors held PharMerica Corporation (PMC) as of Q2 2017, up from 152 in Q1 2017.
  • Funds reported $756M of PharMerica Corporation stock for Q2 2017, up 11% quarter-over-quarter.
  • 15 funds opened new PharMerica Corporation positions in Q2 2017 and 9 closed out, a net change of +6 holders.
  • The largest PharMerica Corporation buyer in Q2 2017 was Discovery Group I, an estimated $12.1M added.
  • The largest PharMerica Corporation seller in Q2 2017 was Fidelity Investments, an estimated $20.7M sold.

Based on aggregated 13F filings for Q2 2017.